5 Results for "

CBP/p300-IN-3

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "CBP/p300-IN-3" in MCE Product Catalog:

Cat. No.: HY-128876
CAS No.: 2299226-01-8
Purity:  98.95%
Research Areas:  

Cancer

CBP/p300-IN-3, a p300/CBP histone acetyltransferase inhibitor, Compound 6, is sourced from patent WO 2019049061 A1 .
loading...
    loading...
Cat. No.: HY-139707
CAS No.: 2484739-21-9
Purity:  98.55%
Synonyms: Thalidomide-NH-CBP/p300 ligand 2
Research Areas:  

Cancer

PROTAC CBP/P300 Degrader-3 (Thalidomide-NH-CBP/p300 ligand 2) is a PROTAC degrader of CBP and p300. PROTAC CBP/P300 Degrader-3 promotes ubiquitination and degradation of CBP/P300. It can be used in the research of prostate cancer .
loading...
    loading...
Cat. No.: HY-161483
CAS No.: 1936425-34-1
Research Areas:  

Cancer

CBP/p300 ligand 3 (conpound 3) is a CBP/p300 bromodomain ligand that binds to the CBP and p300 bromodomains with IC50 values ​​of 1.1 nM and 1.3 nM, respectively. CBP/p300 ligand 3 can be used to synthesize CBPD-268 (HY-161369) .
loading...
    loading...
Cat. No.: HY-187066
CAS No.: 2832964-54-0
Research Areas:  

Others

trans-CBP/p300 ligand 3-cyclohexane-CHO is a target protein ligand-linker conjugate. trans-CBP/p300 ligand 3-cyclohexane-CHO is used for the synthesis of PROTAC CBPD-268 (HY-161369) .
loading...
    loading...
Cat. No.: HY-P11829
Research Areas:  

Cancer

ACTR-AD1 2L is a ACTR-AD1 peptide. ACTR-AD1 2L inhibits CBP/p300-NCOA3 complex formation, modulates gene transcription, inhibits CBP/p300 acetylase activity, reduces acetylation levels, and exhibits antiproliferative activity. ACTR-AD1 2L binds with stronger affinity to its target proteins than the wild-type peptide. ACTR-AD1 2L can be used for the research of breast cancer .
loading...
    loading...